Yuki Gosei Kogyo Co., Ltd. (TYO:4531)

Market Cap	9.72B +72.8%
Revenue (ttm)	15.31B +3.1%
Net Income	663.00M -25.6%
EPS	30.74 -25.0%
Shares Out	21.54M
PE Ratio	14.67
Forward PE	n/a
Dividend	10.00 (2.48%)
Ex-Dividend Date	Mar 30, 2026

Volume	550,800
Average Volume	1,094,365
Open	457.00
Previous Close	473.00
Day's Range	448.00 - 482.00
52-Week Range	214.00 - 640.00
Beta	0.40
RSI	56.49
Earnings Date	Jan 30, 2026

About Yuki Gosei Kogyo

Yuki Gosei Kogyo Co., Ltd. researches, develops, manufactures, and markets fine chemical products in Japan and internationally. It offers food additives, pharmaceuticals, and industrial and agricultural chemicals; and glycine, glycine compounds, nicotinic acid amide, nicotinamide, isoniazid, drug intermediates, and cosmetic ingredients. The company also provides amino acid, pyridine, piperidine, silicon, and other compounds; DNA, nucleoside, and protamine; and active pharmaceutical ingredients. In addition, it engages in the contract manufactur...

• Industry: Chemicals
• Sector: Materials
• Founded: 1947
• Employees: 296
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4531

Financial Performance

In fiscal year 2025, Yuki Gosei Kogyo's revenue was 15.13 billion, an increase of 16.98% compared to the previous year's 12.93 billion. Earnings were 896.00 million, an increase of 15.46%.